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Background: Neonatal infection and sepsis are common for preterm infants due to
their immature immune system. Early diagnosis is important for effective treatment,
but few early markers of systemic and neuro-inflammatory responses in neonates
are known. We hypothesised that systemic infection with Staphylococcus epidermidis
(SE), a Gram-positive bacteria, induces acute changes to proteins in the plasma and
cerebrospinal fluid (CSF), potentially affecting the immature brain of preterm neonates.
Methods: Using preterm pigs as a model for preterm infants, plasma and CSF samples
were collected up to 24 h after SE infection and investigated by untargeted mass
spectrometry (MS)-based proteomics. Multiple differentially expressed proteins were
further studied in vitro.
Results: The clinical signs of sepsis and neuroinflammation in SE-infected
piglets were associated with changes of multiple CSF and plasma proteins. Eight
plasma proteins, including APOA4, haptoglobin, MBL1, vWF, LBP, and sCD14,
were affected 6 h after infection. Acute phase reactants, including complement
components, showed a time-dependent activation pattern after infection. Feeding
bovine colostrum reduced the sepsis-related changes in clinical indices and plasma
proteins. Neuroinflammation-related neuropeptide Y (NPY), IL-18, and MMP-14 showed
distinct changes in the CSF and several brain regions (the prefrontal cortex,
PVWM, and hippocampus) 24 h after infection. These changes were verified in TLR2
agonist-challenged primary microglia cells, where exogenous NPY suppressed the
inflammatory response.
Conclusion: Systemic infection with SE induces inflammation with rapid proteome
changes in the plasma and CSF in preterm newborn pigs. The observed early markers
of sepsis and neuroinflammation in preterm pigsmay serve as novel biomarkers for sepsis
in preterm infants.
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INTRODUCTION
Preterm infants are at a high risk of bacterial infection in the
neonatal period and systemic infections, leading to sepsis, are
important for the overall mortality andmorbidity of these infants
(1, 2). The risk of infection increases with decreasing birth weight
and gestational age (GA) (3) and 25–60% of extremely preterm
infants (GA <28 weeks) experience at least one infection period
in the neonatal period (1). Infections also sensitise preterm
infants to non-inflammatory insults, such as hypoxia-ischaemia,
and may damage many organs, including the immature brain (1).
Infants surviving neonatal sepsis may therefore show increased
morbidity related to the respiratory, gastrointestinal, and nervous
systems (1, 4–6). Increased susceptibility to infection in preterm
infants in the neonatal period can be partly explained by delayed
development of the immune system, which may persist into
childhood and even adulthood (1, 7). The use of invasive
procedures and parenteral nutrition during hospitalisation
further predispose preterm infants to systemic infection and
inflammation (8).
In neonatal intensive care units, Gram-positive bacteria, such
as coagulase-negative staphylococci (CoNS), are often observed
as causative pathogens in neonatal infection (3). In surveillance
data from the UK, Gram-positive bacteria were causative in 70%
of late-onset sepsis (LOS) cases, with 42% due to CoNS (8).
Staphylococcus epidermidis (SE), a skin commensal bacteria, has
been reported to be responsible for up to 50% of LOS cases
(9). Unlike Gram-negative bacteria, which triggers the immune
response of the host via a lipopolysaccharide (LPS) to activate
Toll-like receptor 4 (TLR4), SE triggers the host response mainly
via TLR2 (10). In our previous study, bloodstream infection
with live S. epidermidis caused multiple signs of sepsis in
preterm neonatal pigs, such as lethargy, hypotension, respiratory
acidosis, internal organ haemorrhage, and neuroinflammation
(11). Even without the entry of bacteria into the central nervous
system (CNS), Gram-positive infections can cause cerebral
inflammation via the activation of TLR2 and are associated with
white matter injury and impaired neurodevelopment (10). The
systemic administration of a synthetic TLR2 agonist, Pam3CSK4,
adversely affects brain development in newborn mice (12),
Abbreviations: APOA4, apolipoprotein A-IV; APPs, antimicrobial proteins
and peptides; aSOFA, SOFA score adapted to preterm piglets; BCB, blood-
CSF barrier; C1QA, complement C1q A chain; C1R, complement C1r; C5,
complement C5; CFU, colony-forming units; CNS, central nervous system; CoNS,
coagulase-negative staphylococci; CRP, C-reactive protein; CSF, cerebrospinal
fluid; ECM, extracellular matrix; FDR, false discovery rate; GA, gestational
age; HP, haptoglobin; HPX, hemopexin; IgG, immunoglobulin G; IHC,
immunohistochemistry; IL-18 BP, IL-18 binding protein; IL-18, interleukin 18;
LBP, LPS-binding protein; LOS, late-onset sepsis; LPS, lipopolysaccharide; LTA-
SA, lipoteichoic acid from S. aureus; MBL1, mannose-binding lectin (protein A)
1; MMP-14, matrix metalloproteinases 14; MS, mass spectrometry; MT-MMPs,
membrane-type matrix metalloproteinases; NPY 1R, neuropeptide Y receptor type
1; NPY, neuropeptide Y; Pref cortex, prefrontal cortex; PVWM, paraventricular
white matter; SAA, serum amyloid A; sCD14, soluble CD14; SE, Staphylococcus
epidermidis; SEM, standard error of the mean; SOFA, sequential organ failure
assessment; TLR, toll-like receptor; TLR2, toll-like receptor 2; TLR4, toll-like
receptor 4; TNF-α, tumour necrosis factor-α; VCAM1, vascular cell adhesion
protein 1; vWF, von Willebrand factor.
suggesting TLR2 activation has a key role in brain injury
associated with Gram-positive infection in neonates.
Prompt diagnosis of infection in preterm infants is difficult
as the clinical manifestation is often variable, subtle, and further
complicated by non-infectious conditions (13), resulting in
delayed or suboptimal treatment. Moreover, antibiotic treatment
for treating sepsis alone does not decrease the risk of sepsis-
associated cerebral injury (1). Early enteral feeding has been
recommended to prevent infections, and antimicrobial proteins
and peptides (APPs, e.g., lactoferrin) have been suggested as
adjunctive therapies (8). Our previous report showed that early
oral feeding of bovine colostrum, rich in bioactive components,
can dampen the systemic inflammation caused by Gram-
positive infections in preterm pigs (11). In this study, we
hypothesised that a Gram-positive infection rapidly alters the
inflammatory proteome in the plasma and cerebrospinal fluid
(CSF), and enteral feeding mitigates these changes. Sequential
plasma collections (6, 12, and 24 h after infection) were
used to search for early systemic proteome responses that
may provide new targets for more timely sepsis diagnosis
and treatment. CSF proteins were profiled to reveal changes
pertaining to neuroinflammation in the surrounding CNS. The
potential inflammatory effect of selected brain proteins, including
NPY, a neuroimmune messenger (14–16) and memory and
learning regulator (16, 17), and IL-18, a pro-inflammatory
cytokine related to inflammation and blood–CSF barrier
integrity (18–20), were further investigated using in vitro cell
culture systems.
METHODS
Animal Procedure
The delivery, rearing, inoculation, and euthanasia of the
premature piglets were carried out as previously described (11)
and are schematically presented in Figure 1A. Briefly, preterm
piglets (n = 40) delivered from two sows (Danish Landrace ×
Large White × Duroc) via caesarean section at 91% gestation
age (107 ± 1 d) were individually incubated with heating (37–
38◦C) and an oxygen supply. Each piglet was fitted with one
vascular catheter (4F, Portex, Kent, UK) into the dorsal aorta
via the umbilical cord and an orogastric tube (6F, Portex).
Pareteral nutrition and eternal nutrition for each piglet, if
applicable, started immediately after the catheterisation. A group
of piglets was intra-arterially inoculated with live Staphylococcus
epidermidis (SE) re-suspended in sterile saline (1.0× 109 CFU/kg
bw; bw, body weight) over 3min. Fourteen inoculated piglets
received enteral feeding of bovine colostrum (10 mL/kg bw/3 h,
Biofiber-Damino, Gesten, Denmark) via the orogastric tube and
parenteral nutrition (3 mL/kg bw/h) via the umbilical catheter
(SE+ENT, n = 14). The remaining inoculated pigs received
parental nutrition (6 mL/kg bw/h, SE, n = 15) only. Piglets
that were not inoculated and only received parenteral nutrition
(6 mL/kg bw/h) served as controls (Control, n = 11). The
parenteral nutrition was formulated, as previously described,
based on Kabiven (Fresenius-Kabi, Bad Homburg, Germany)
and modified to meet the requirement of preterm pigs with
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FIGURE 1 | Overview of the animal procedure and the proteomic analysis. (A) Animal procedure; (B) numbers of samples adopted in the proteomic analysis; (C)
numbers of proteins with differential abundance in both the CSF and plasma (24 h); (D) numbers of plasma proteins with differential abundance at 6, 12, and 24 h
post-infection. Numbers in (C,D) are numbers of proteins showing difference in any comparison between the treatment groups and are different from those in (B) and
Table S2 specifying difference between treatment groups.
added vitamins and minerals (Soluvit, Vitalipid, and Peditrace,
Fresenius-Kabi) (11).
At 6, 12, and 24 h post-inoculation, blood was obtained from
the umbilical arterial catheter from each piglet for bacteriological,
haematological, and blood gas analyses, and EDTA-treated
plasma was separated and saved at−80◦C for proteomic analysis.
Sodium fluorescein (2%, 5 mL/kg bw, Sigma-Aldrich, Brøndby,
Denmark) was administered via the umbilical catheter 30min
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before the scheduled euthanasia for assessment of blood–CSF
barrier permeability. Under anaesthesia, piglets were euthanised
with a lethal intracardial injection of sodium barbital (Apotek,
Glostrup, Denmark). CSF was directly collected by sub-occipital
puncture from each piglet and save at −80◦C for proteomic
analysis. CSF samples with possible blood contamination,
examined by oxyhemoglobin absorbance (λ = 414 nm), were
discarded. The number of CSF and plasma samples applied to
the proteomic analysis are shown in Figure 1B.
The right hemisphere of the brain was fixed in ice-
cold 4% paraformaldehyde for immunohistochemistry (IHC),
and different brain parts, including the prefrontal cortex,
paraventricular white matter (PVWM), and hippocampus, of the
left hemisphere were dissected, snap-frozen, and saved at−80oC
for later analysis. Animals were treated in compliance with the
Animal Experimentation Act of Denmark, which is in accordance
with the Council of Europe Convention ETS 123. The study
was approved by the Danish National Committee on Animal
Experimentation (2014-15-0201-00418).
Mass Spectrometry (MS)-Based
Proteomics
The preparation of protein samples was performed using
a filter-aided protocol, as previously described (21). Protein
concentration was determined by the absorbance at 280 nm on
a NanoDrop Spectrophotometer (Thermo Scientific, Waltham,
MA, USA) with bovine serum albumin (BSA) as a standard. CSF
or a plasma sample containing 100 µg protein was transferred
onto an Amicon Ultra centrifugal filter (10 kDa, 0.5mL,
Millipore, Søborg, Denmark) and mixed with a buffer containing
sodium deoxycholate (5%) and triethylammonium bicarbonate
(50 mmol/L, pH 8.0). The protein was reduced by TCEP solution
[0.5 mol/L, 1:50 (v/v)], alkylated by chloroacetamide [0.5 mol/L,
1:50 (v/v)], and digested by trypsin (Promega, 1 µg/100 µg
protein, 37 ◦C overnight) inside the spin filter with a centrifuge
step (14,000 × g for 15min) in between. Tryptic peptides were
recovered by another step of centrifugation and purified by phase
extraction using ethyl acetate acidified by trifluoroacetic acid (1%,
v/v). Vacuum-dried peptides were suspended in a solution of 2%
acetonitrile, 0.1% Formic acid, and 0.1% trifluoroacetic acid and
applied onto a Dionex RSLC UPLC System (Thermo Scientific)
coupled to a Q-Exactive HF Hybrid Quadrupole-Orbitrap Mass
Spectrometer (Thermo Scientific) for analysis. A total of 5 µg
of peptide was injected onto a 2 cm reverse-phase C18 material
trapping column and separated on a 50 cm analytical column
(Acclaim PepMap100, 75µm ID, 100 Å, Thermo Scientific) with
both columns kept at 40◦C. The elution gradient was set at a
constant flow rate of 300 nL/min and started with a mixture of
water (96%) and acetonitrile (4%) containing 0.1% formic acid;
it was then increased to 30% acetonitrile over 225min. Mass
spectrometric data were obtained in positive ionisation mode
in a data-dependent acquisition fashion with survey spectra
and isolation/fragmentation spectra alternating using a top 12
method. Selected peptides were excluded from re-analysis for
30 s. All samples were analyzed in duplicates in a random order.
Protein annotation and quantification based on mass spectra
of peptides were carried out using a MaxQuant (version 1.5.2.8)
(22) against the UniProt reference database with isoforms (Sus
scrofa, UP000008227, last modified 2016-08-02) (23). Raw data
was searched using an internal re-calibration at 4.5 ppm using
two missed cleavages. Cysteine carbamethylation was set as fixed
modification and methionine oxidation as variable modification.
Allowable missed cleavages were set as 1. The detection of at least
two unique peptides per protein and a protein being present in
at least 70% of samples in each group were required criteria for
protein annotation and quantification. Common contaminants
and reverse decoy matches were removed from the annotated
protein list. Using the Perseus software (version 1.2.0.17) (24),
protein abundance data were normalised and the two-based
logarithm transformed to conform to normal distribution and
to reduce variability from data acquisition, which was aligned
with protein identities and grouping information, such as the
treatment and the litter (sow). Aligned data were exported into R
(version 3.4.1) (25) and integrated with R Studio (version 3.1.18)
(26) for data analysis. The MS proteomic data are available at the
ProteomeXchange Consortium (http://www.proteomexchange.
org/) with the data set identifier PXD016013.
Primary Culture of Microglial Cells
The primary culture ofmicroglial cells was prepared as previously
described (27) with minor modifications. In brief, hippocampi
obtained from preterm piglets from another litter were chopped
in ice-cold Krebs-Ringer modified buffer and digested with
trypsin for 10min at 37◦C (all from Sigma-Aldrich). Pelleted
cells were then washed in the presence of DNase and trypsin
inhibitor, re-suspended in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 100µg/mL penicillin, 100 U/mL
streptomycin, and 10% heat-inactivated foetal bovine serum
(FBS; all from Gibco, Taastrup, Denmark), and kept in cell
culture flasks (NUNC, Roskilde, Denmark) to reach confluence.
Microglial cells were collected from the supernatant by shaking
the culture flask at 250 RPM at 37◦C for 4 h. Isolated microglial
cells were re-seeded into either 6-well-plates at the density of
25,000 cells/cm2 for gene expression analysis or 96-well-plates at
the density of 250,000 cells/cm2 for ELISA. After overnight rest
and growing in serum-free medium for 8–12 h, microglial cells
were treated, in duplicates, with either 2.5µg/mL LTA-SA (from
S. aureus, InVivoGen, Toulouse, France) or 20 ng/mL Pam3CSK4
(InVivoGen) alone or in the presence of 0.5µM exogenous
NPY peptide (synthetic human NPY, Schafer-N, Copenhagen,
Denmark) for 24 h. The level of tumour necrosis factor-α (TNF-
α) in the culture was determined in triplicates using porcine
DuoSetELISA kits (R&D Systems, Minneapolis, MN, USA).
To estimate the purity of the culture, microglial cells,
isolated as described above, were plated into PLL-coated 8-
well-Lab-Tek R© Permanox chamber slides (NUNC), allowed to
grow for 24 h, fixed with 3.7% (v/v) formaldehyde and 1%
(v/v) methanol in PBS, and stained with anti-Iba1 antibody
(1:2,000, rabbit, ab5076, Abcam, Cambridge, UK) followed by
secondary Alexa Fluor 488-conjugated antibody (1:1,000, goat
anti-rabbit, Molecular Probes). Cell nuclei were counterstained
by DAPI using mounting media (Molecular Probes). Images
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were recorded using an Axiovert 100 microscope (Zeiss, Jena,
Germany) equipped with an AxioCam MRm camera (Zeiss) and
ZEN 2012 software (Zeiss). The enriched microglia culture was
90% pure, as determined by the ratio of Iba-1-positive cells to
total cells (Figure S1).
Immunohistochemistry (IHC)
To localise the cerebral neuropeptide Y (NPY) in the brain
tissue, brain sagittal sections (5µm) were probed with primary
antibody against NPY (rabbit, 1:3,000, ab30914, Abcam) and a
biotin-conjugated secondary antibody (goat-anti-rabbit, 1:500,
Vector Labs, Peterborough, UK) after standard deparaffinisation,
rehydration, antigen retrieval, and blocking procedure. Staining
was visualised with 0.04% 3,3′-diaminobenzidine (DAB, Sigma-
Aldrich) using an ABC Peroxidase Staining Kit (Thermo
Scientific). For the quantification of NPY expression in brain,
whole sections were scanned at a 10 × objective magnification
on a Zeiss Axio Scan Z1 (Zeiss). The region of interest was
selected in similar anatomical regions across samples, and
the number of NPY-positive cells was counted in the defined
frames. Representative images were acquired with a BX-51
microscope (Olympus, Ballerup, Denmark) using Integrator
System software (Visiopharm).
ELISA
The concentration of IL-18 in CSF and plasma samples
was measured with a porcine IL-18 ELISA kit (RayBiotech,
Norcross, Georgia, USA). The frozen tissue of two brain
regions, the prefrontal cortex and PVWM, was homogenised
and lysed for protein extraction. Total protein concentration
was determined by a PierceTM BCA kit (Thermo Scientific,
Waltham, Massachusetts, U.S) for total protein adjustment
later. The concentration of NPY in two brain regions was
measured with a porcine Neuropeptide Y (NPY) ELISA kit
(Phoenix Pharmaceuticals, Burlingame, CA, USA), and the final
concentration was adjusted to total protein concentration.
Gene Expression by Real-Time qPCR
Transcription of selected genes in the prefrontal cortex, PVWM,
and hippocampus was determined by real-time qPCR, using
predesigned primers (sequences listed in Table S5). Briefly, total
RNA in tissue homogenate was isolated with RNeasy Lipid
Tissue Mini Kit (Qiagen, Copenhagen, Denmark). RT-qPCR was
performed using a QuantiTect SYBR Green PCR Kit (Qiagen)
on a LightCycler 480 (Roche, Hvidovre, Denmark). The relative
level of target genes was normalised to the housekeeping gene
HPRT1 (28).
Data Analysis and Statistics
Before analysis, the mean protein abundance of three technical
replicates of each sample in the proteomic analysis were
combined into one as previously described (29). An univariate
analysis was applied to proteomics data in each sample type (CSF
or plasma) at each sampling time-point in R. Briefly, a linear
mixed-effect model was fitted to each protein with treatment
as the fixed-effect factor and litter as a random-effect factor
using the lme4 package (30). A Tukey post-hoc test (package
multcomp) on this model was adopted to compare the effect
between three treatment groups, i.e., Control, SE, and SE+ENT,
in a pairwise fashion (31). To control the type I error, p-values
were further adjusted by false discovery rate (FDR, α = 0.2) into
q values within each comparison of each sample type (plasma
or CSF) at each time-point using the multtest package (32).
Proteins with a q ≤ 0.10 in any comparisons were chosen
for functional assignment, which is generally accepted for this
kind of explorative proteomic analysis. Dunn’s Kruskal-Wallis
Multiple Comparisons test of various clinical data and Pearson’s
correlation test were conducted in R. Results from RT-qPCR and
ELISA were analyzed using a Student’s t-test and a two-tailed
p < 0.05 was considered as statistically significant. Data were
presented as mean± SEM unless otherwise stated.
RESULTS
Clinical Data
As shown in our previous report, preterm piglets inoculated
with live SE developed sepsis and blood–CSF barrier disruption,
and enteral feeding ameliorated these damages (11). The clinical
variables of the piglets included for proteomic analysis, namely
the aSOFA score, leucocyte count in the CSF and blood, platelet
count in blood, and CSF–blood fluorescein ratio, are presented
in Table S1. Similar to our previous report, the SOFA score
adapted to preterm piglets (aSOFA), CSF leukocyte count, blood
levels of C-reactive protein (CRP), and fibrinogen at 24 h were
elevated after SE infection (all p < 0.05), indicating sepsis and
elevated systemic and intracranial immune response in the SE
piglets. Blood–CSF barrier permeability was higher in SE piglets,
as shown by the higher CSF-serum fluorescein ratio (p < 0.05)
relative to the controls. The blood leukocyte number decreased
after birth (p < 0.05) in Control, while SE infection maintained
the leukocyte count over time (p = 0.91), although generally
lower than in Controls. The blood leukocyte number in SE +
ENT piglets tended to decrease over time (p = 0.08), similar
to Control, but at a lower level. The platelet number increased
over time in all three treatment groups, while the value in SE
piglets was lower than that in Control and SE+ENT pigs (p <
0.05 for all comparisons between treatment groups, except SE
vs. Control at 24 h). The values in SE+ENT pigs were similar to
those in Control.
CSF and Plasma Proteomics
No significant difference in the protein concentration of CSF
samples was observed among the three groups (P = 0.17) as
tested by a linear model including factors such as treatment,
sex, and litter. In CSF and plasma samples, 1,960 and 735
proteins were annotated (as shown in Data Sheets S1 and S2),
respectively, and 86 CSF proteins and 114 plasma proteins
that met the selection criterion (q ≤ 0.1 in at least one
treatment comparison) were selected for functional assignment
(Figure 1C). The numbers of differential proteins in any
comparison in the CSF and plasma at the different time-points
are listed in Figures 1B–D and Table S2. Among the selected
CSF proteins, 83 showed differential expression between SE vs.
Control, while 27 showed differential expression for SE+ENT
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vs. Control and 1 for SE + ENT vs. SE. In plasma, the number
of differential proteins (SE vs. Controls) increased over time,
10, 43, and 109 at 6, 12, and 24 h, respectively (Figure 1D).
Twenty-one proteins with differential abundance appeared in
both the CSF and 24 h plasma, and proteins, such as serpin
G1, von Willebrand factor (vWF), LPS-binding protein (LBP),
haptoglobin, hemopexin (HPX), MRC1, and VCAM1, changed
similarly in the CSF and 24 h plasma (Figure 2). Seven plasma
proteins, including haptoglobin, vWF, serpin a3-8, serpin a3-
6, sCD14, LBP, and apolipoprotein A-IV, maintained their
differential abundance pattern across three time-points, although
at different significance levels (Figure 1D).
According to their major physiological functions, listed in
the Uniprot database and publications, differential proteins
were categorised into groups including “neurodevelopment
(development),” “immune response,” “protein processing,”
“metabolism,” and “others.” Observed acute phase reactants
were categorised as a separate group. The protein groups may
show overlap and are not mutually exclusive. Information on
proteins with differential abundance, including UniProt ID, gene
name, protein name, and abundance in each group, is shown in
Tables S3, S4.
Immune Response Proteins
In the CSF, 38 differential proteins were related to immune
response (45% of all regulated proteins, Table S3), whereas 48
(44%) immune-related proteins were detected in plasma at 24 h,
24 (56%) at 12 h, and 8 (80%) at 6 h (Table S4). All differential
immune response proteins, including acute phase reactants, in
the CSF were affected by the SE infection (SE vs. Control).
None of these proteins, except IL-18 BP, were affected by enteral
feeding (SE+ENT vs. SE). Fifteen of 21 proteins present in
both the CSF and 24 h plasma were associated with immune
response, including A2M, BF, C1R, C5, CPN2, HP, HPX, ITIH1,
ITIH4, KNG1, LBP, Serpin A3-8, MRC1, SAA2, and APOB
(Figure 2 and Tables S3, S4). Among them, A2M, ITIH1, KNG1,
and APOB were elevated in the CSF of SE pigs relative to the
Control, but decreased in 24 h plasma. The remaining proteins
showed elevated abundance in both types of samples after SE
infection (Figure 2). At 24 h, 45 of the 62 differentially regulated
proteins in plasma by SE were also affected by the enteral feeding
(SE+ENT vs. SE, q < 0.1), 16 proteins were affected at 12 h, but
only 5 proteins at 6 h.
Neuropeptide Y (NPY)
Neuropeptide Y (NPY) was only detected in the CSF samples
and not in plasma samples, and it was detected at a lower
level in the SE pigs relative to the Control (Figure 3A). In
the brain tissue, NPY transcription is lower in the prefrontal
cortex and PVWM in SE piglets relative to the Control, while
enteral feeding increased the transcription of NPY and one of its
key receptors, NPY 1R, in the prefrontal cortex (Figures 3B,C).
Unlike that in the prefrontal cortex, transcription of NPY (p
< 0.05) and NPY 1R (p = 0.08) in the hippocampus increased
after SE infection, but no effect of enteral feeding was observed.
The protein level of NPY in two brain regions, the prefrontal
cortex and PVWM, was significantly lower in SE piglets,
which was consistent with the transcription and proteomic data
(Figure 3D). Immunohistochemical staining for NPY in selected
brains confirmed its presence within the same brain regions
(Figure 3G).
In a previous study, the immuno-positive brain area against
Iba-1, a marker for microglial cells, significantly increased in the
SE group compared with the controls, but it was not significantly
affected by the colostrum feeding (11). Therefore, to investigate
the direct response of microglial cells to acute SE stimulation,
a primary porcine cell culture was employed. In this culture,
stimulation for 24 h with TLR2 agonists (LTA-SA, Pam3CSK4)
decreased NPY transcription (p < 0.01, Figure 3E) but increased
the transcription of NPY 1R (only by Pam3CSK, p < 0.05,
Figure S1B). Treatment with exogenous NPY upregulated the
transcription of NPY (vs. LTA-SA alone, p < 0.01, Figure 3E)
and NPY 1R (vs. Pam3CSK4 alone, p < 0.05, Figure S1B).
Further, exogenous NPY (0.01, 0.10, 0.50, and 1.00µmol/L) dose-
dependently suppressed the production of TNF-α triggered by
TLR2 agonists (Figure 3F).
IL-18, IL-18 BP, and MMP-14
In the CSF, IL-18 binding protein (IL-18 BP) was only detected
in the SE and SE + ENT groups, with the highest level being
in SE pigs (q < 0.05, Figure 4A). Levels of IL-18 in the CSF
and plasma (24 h) of SE piglets, determined by ELISA, were
elevated when compared with the Control (both p < 0.05,
Figures 4B,C), but enteral feeding decreased IL-18 levels (both
p < 0.05, Figures 4B,C). In the hippocampus and PVWM, IL-
18 transcriptions were higher in the SE than in the Control and
SE+ENT pigs (all p< 0.05, Figure 4D). In the primarymicroglial
culture, IL-18 expression was upregulated by TLR2 agonists (p <
0.01, Figure 4E).
The CSF level of MMP-14 was higher in SE piglets than that in
Control (q < 0.05), while no significant difference was observed
between SE+ENT and SE piglets (Figure 4F). Similarly,MMP-14
transcription increased relative to the Control in the brain of SE
piglets as well as in TLR2 agonist-challenged primary microglial
cells (all p < 0.05, Figures 4G,H).
Acute Phase Reactants
Multiple acute phase reactants were detected in the CSF and
plasma after SE infection, including those related to opsonisation
(CRP, SAP, C1q), SAA, coagulation factors (fibrinogens, factor
VIII and vWF), α-2-macroglobulin, microbial iron uptake-
inhibiting haptoglobin, and complement components and
various serpins including α-1-antitrypsin (Table S4). These
“positive” acute phase reactants increased post-SE infection,
while multiple ‘negative’ acute phase reactants decreased,
including albumin, transferrin, transthyretin, and retinol-
binding protein 4 (Table S4).
Multiple immune response proteins, including Serpin A3-
6, Serpin A3-8, MBL1, vWF, haptoglobin, LBP, and sCD14,
increased in abundance as early as 6 h post-SE infection. Most
proteins, including LBP, vWF, Serpin A3-6, and Serpin A3-
8, maintained this change until 24 h (all p < 0.05, Figure 5).
In 24 h plasma, C1QA, C1R, C2, C5, C6, C8B, and C4BPA
increased in SE piglets relative to the Controls. Increases in
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FIGURE 2 | Twenty-one differentially expressed proteins present in the CSF and plasma 24 h post-infection. A majority of these proteins, 15 of 21, present in both the
CSF and 24 h plasma were associated with immune response, most of which changed in the same direction. Fold changes of SE/Control and SE+ENT/SE of specific
proteins are displayed in bars. *SE vs. Control; #SE vs. SE+ENT; * or #, q, or p < 0.05; ** or ##, q, or p < 0.01; *** or ###, q, or p < 0.01.
C1R, C1QA, and C5 levels were observed in 12 h plasma as
well (all p < 0.05, Figure 6). However, no C3 and C4 were
observed with differential abundance in plasma within 24 h.
ApoA4 increased significantly in the SE+ENT group from 6 h to
24 h when compared with the Control and SE groups (all p <
0.001, Figure 5).
DISCUSSION
In this study of systemic infection with SE-induced sepsis and
neuroinflammation, preterm pigs were used as a model for
preterm infants. Within 24 h of SE infection, a large number of
proteins related to the immune response were affected in the
CSF and plasma, and a number of proteins (genes) had their
expression affected in various brain regions. Enteral feeding with
bovine colostrum modified the proteome response in plasma
within 24 h, while less CSF proteins were affected within this
time frame. Collectively, these results suggest that plasma and
CSF proteins may be a rich source of early biomarkers for sepsis
and neuroinflammation in preterm neonates. Furthermore, they
show that early enteral feeding may be important in dampening
the systemic and brain inflammatory response to infection.
Besides activating leukocytes, the systemic immune system
may enlist proteins supporting immune response to enter the
CNS. In the current study, 15 immune response-related proteins
changed in abundance in both the CSF and plasma following SE
infection, and most of them changed in the same direction. The
majority of these proteins were related to immune defence, for
example, KNG1 was involved in blood coagulation and platelet
degranulation. Other proteins were involved in acute phase
response, such as A2M, properdin, C1R, C5, CPN2, haptoglobin
(inhibition of microbial iron uptake), serpins (inter-α-trypsin
inhibitors), and SAA (immune cell recruitment). LBP and sCD14
(presepsin), involved in TLR4 activation, were also stimulated by
SE infection (Table S4), confirming results from newborn infants
(33); a Gram-negative infection, however, may induce even a
higher level of sCD14 than a Gram-positive infection (34). The
SE-elevated proteins found in the CSF may partly originate from
the systemic circulation and travelled through a more permeable
blood–CSF barrier in these preterm pigs. Of many proteins,
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FIGURE 3 | Proteomics, brain transcription, and in vitro analyses of NPY. (A) Protein level of NPY in CSF decreased post-infection; (B) transcription of NPY decreased
by SE infection in two brain regions, the prefrontal cortex and PVWM, but increased in the hippocampus; (C) transcription of NPY 1R increased by colostrum feeding
in prefrontal cortex and PVWM; (D) protein level of NPY in significantly down-regulated by SE infection; (E) transcription of NPY in cultured primary microglia cells
challenged by TLR2 agonists alone and in combination with NPY (0.5µM); (F) secreted TNFα level in primary microglia culture co-treated with LTA-SA, Pam3CSK4,
and NPY for 24 h. The TNFα level was decreased by exogenous NPY; (G) NPY-positive cells in prefrontal cortex, PVWM, and hippocampus. All data are presented as
mean ± SEM. White squares are magnified inserts. Scale bar, 100µm. *, q, or p < 0.05; **, q, or p < 0.01; ***, q, or p < 0.001.
enteral feeding of bovine colostrum only affected the plasma
level (Tables S3, S4), suggesting that enteral feeding, at least with
bovine colostrum,mainly affected the systemic inflammation and
had a limited effect inside the CNS, at least in this short term.
The brain inflammatory response was demonstrated by the
SE-induced change in abundance of 38 CSF proteins that
were related to neuroinflammation and 23 proteins related to
neurodevelopment, including glial cell differentiation, astrocyte
migration, and synaptic adhesion (Table S3). Among these
proteins, neuropeptide Y (NPY), a neuropeptide in the CNS
with pleiotropic roles in neurogenesis, neuroprotection, and
neuroinflammation (35), showed decreased abundance in the
CSF after SE infection. NPY mediates the interaction between
the nervous and immune systems (35) and may be involved
in the activation of resident immune cells; microglia and its
upregulation may counteract inflammatory processes (36). In
the current study, differential expression of NPY in three brain
regions of SE-infected pigs (the prefrontal cortex, PVWM, and
hippocampus) indicates that brain-derived NPY, at least in part,
contributes to the altered NPY level in SE-infected CSF. On the
other hand, circulating NPY may also have contributed to the
NPY levels in the CSF, especially in the light of the elevated
blood–CSF permeability post-SE infection. Unlike that in the
prefrontal cortex and PVWM, the hippocampal expression of
NPY was elevated in the SE group. Besides, elevated transcription
of NPY 1R, one key receptor of NPY, was only found in the
hippocampus of SE piglets, supporting other studies (37). Our
results suggest that SE infection triggers highly distinct responses
in different brain regions of preterm neonates.
Microglial cells, the resident macrophages in the brain,
provide an immune defence that involves TLRs and are a key
source of NPY production (35). Primary porcine microglial
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FIGURE 4 | IL-18 BP, IL-18, and MMP-14 in CSF, plasma, brain tissue, and cultured microglia. (A) IL-18 BP level in the CSF detected only in SE and SE+ENT piglets;
(B,C) IL-18 levels in the CSF and plasma, both significantly upregulated by SE infection; (D) transcription of IL-18, significantly increased in the SE group in three brain
regions and decreased by enteral feeding of colostrum in the PVWM and hippocampus; (E) transcription level of IL-18 in primary microglia, significantly increased by
the treatment of TLR2 agonists; (F) protein level of MMP-14 in the CSF, increased in SE pigs; (G) transcription level of MMP-14 in three brain regions, increased by SE
infection; (H) transcription level of MMP-14 in primary microglia, increased by the treatment of TLR2 agonists. Data are presented as mean ± SEM. *, q, or p < 0.05;
**, q, or p < 0.01; ***, q, or p < 0.001.
cells decrease their expression of NPY when treated with
TLR2 agonists, indicating that microglial cells are involved
in the altered expression of NPY after SE infection. Surely
this does not exclude the potential contribution of other
neuronal cells to NPY level in the CNS. NPY works in an
autocrine fashion via its receptor, NPY 1R, to control the
microglia neuroinflammatory response (35). This is consistent
with our observation that exogenous NPY reduced the TNF-
α related inflammatory response in TLR2-challenged microglial
cells, similar to its previously documented effects on LPS-
inducedmicroglial production of IL-1β (38). Enteral feeding with
colostrum dampened the neuroinflammation (reduced leukocyte
count and CRP levels), but did not affect the NPY level in the
CSF, suggesting that dietary modulation of neuroinflammation
did not affect cerebral NPY production. Nevertheless, our data
suggest that exogenous NPY may have the potential to suppress
neuroinflammation in preterm neonates.
IL-18 is a pro-inflammatory cytokine, and the levels of
it in CSF and plasma increase during bacterial meningitis
(39) and sepsis (40). In our study, the CSF and plasma
levels of IL-18 increased in SE piglets relative to Controls,
as did the physiological inhibitor, IL-18 BP (34), in the CSF.
The IL-18 transcription level increased only in PVWM and
the hippocampus of SE piglets, not in the prefrontal cortex.
In isolated preterm pig microglial cells, IL-18 transcription
increased following TLR2 stimulation. Together, these confirm
the cerebral contribution to the elevated IL-18 level in the CSF
during SE infection. The elevated IL-18 BP level in CSF, probably
recruited from the systemic circulation, may exacerbate the
intracranial inflammation, as IL-18 BP can neutralise the action
of IL-18 in counteracting invading bacteria. Enteral feeding
reduced the infection-induced IL-18 response, as shown by
lowered abundance of IL-18 and IL-18 BP in CSF and plasma and
decreased IL-18 transcription in brain tissues.
Neuroinflammation involving IL-18 affects membrane-type
matrix metalloproteinases (MT-MMPs) (18). CSF abundance
of MMP-14, a MT-MMP, and its transcription in the brain
tissues increased in SE-infected piglets relative to the Controls,
in accordance with other studies (41). Being a proteinase-
cleaving extracellular matrix (ECM) protein, MMP-14 inreases
its level to digest the tight junction of the blood–CSF barrier
and basement membrane to allow immune cells to enter the
brain parenchyma to attack invading bacteria (42); increased
levels of leukocytes and platelets were also observed in this study.
Our results suggested that this MMP-14 regulation in the CNS
involved the activation of microglia cells via TLR2. Furthermore,
no clear effect of the enteral feeding on MMP-14 abundance
in the CSF or its transcription in brain tissues was observed.
Together with the limited effects of enteral feeding of colostrum
on other proteins in the CSF, this suggests that early enteral
feeding mainly has an impact on systemic inflammation but not
on neuroinflammation.
Among the early response proteins in plasma, eight showed
differential abundance as early as 6 h post-infection, and these
included haptoglobin, Serpin A3-6, Serpin A3-8, vWF, LBP,
sCD14, MBL1, and APOA4 (Table S4). Haptoglobin, LBP, and
the serpins in particular responded with a clear linear increase
in plasma levels over the first 24 h after SE infection, suggesting
their high relevance as early markers of sepsis and bacterial
infection. On the other hand, enteral feeding increased, rather
than reduced, the levels of these proteins (plus sCD14 and
ApoA4) in plasma. Thus, the immune-dampening effect of
enteral feeding is not mediated by a reduction in haptoglobin,
LBP, serpins, sCD14, and ApoA4 in plasma, and colostrum
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FIGURE 5 | Abundance change of plasma proteins over time. (A) haptoglobin, (B) LBP, (C) vWF, (D) sCD14, (E) Serpin A3-6, (F) Serpin A3-8, (G) ApoA4, and (H)
MBL1. Immune response proteins increased in abundance as early as 6 h post-SE infection, and most of those proteins maintained this change until 24 h. Data are
presented as mean ± SEM. *SE vs. Control; #SE+ENT vs. SE; * or #, q, or p < 0.05; ** or ##, q, or p < 0.01, *** or ###, q, or p < 0.01.
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FIGURE 6 | Plasma level of complement components. (A) C1R, (B) C1QA, (C) C5, C1QA, C1R, and C5 showed change 12 h after SE infection, and C2, C4BPA, C5,
and C8B showed changes 24 h after infection. Data are presented as mean ± SEM. *SE compared to Control; #SE+ENT compared to SE; *or #q < 0.05; ** or
##q < 0.01, *** or ###q < 0.01.
may even stimulate their synthesis, independently of any direct
effect on inflammation. By contrast, enteral feeding reduced
the level of vWF, a coagulation factor, as early as 6 h after
infection. The level of vWF was negatively correlated with mean
platelet counts, confirming that vWF localises platelets to the
endothelial surface in sepsis (43). Plasma vWF is reported to
be more active in infants than in adults, and vWF can be the
first haematological sign of sepsis (44). Collectively, the results
suggest that the plasma vWF level may serve as an early indicator
of sepsis as well as the immunomodulatory effects of early
colostrum feeding.
Among the plasma proteins related to development,
metabolism, and protein processing, 14 proteins were affected
at 12 h, with 13 affected by SE and only three by enteral feeding
with colostrum. At 24 h, 33 of 46 proteins were affected by SE
infection and 21 by enteral feeding. None of the 46 CSF proteins,
except IL-18, were affected by enteral feeding. Combined with
the observation of immune response proteins, this supports
that enteral feeding for 24 h had limited short term effects
on protein levels in the CSF after SE infection. During sepsis,
multiple complement proteins may enter the CNS and engage
in neuroinflammation (45). It was not until 12 h after SE
infection that plasma complement factors (e.g., C1QA, C1R, and
C5) changed in concentration and other complement factors
(C2, C4BPA, C5, and C8B) were affected at 24 h. The small
activation fragments affected by SE infection, such as C3, C4a,
and C5a, increase the permeability of blood vessels and attract
leukocytes (8, 20, 21). The complement system also plays a role
in eliminating invading bacteria and regulating the immune
response to CNS infection by another Gram-positive bacteria,
Streptococcus pneumonia (46). C1q, MBL1, and properdin may
play a role in initiating the lectin and alternative complement
pathways. Considering that MBL1 showed a difference already
at 6 h, while C1q and properdin showed differences at 12 and
24 h, it is possible that there is a time-dependent activation of the
three complement pathways in sepsis.
Many of the proteins that responded to SE infection and
enteral feeding with colostrum warrant further investigation,
including NPY, IL-18, and MMP-14, due to their roles in
neuroinflammation, microglia activation, and blood–CSF barrier
disruption. It is possible that exogenous NPY may be used to
dampen neuroinflammation in newborns. Two of the detected
proteins in plasma, IL-18 and sCD14, show a differential response
to Gram-positive and Gram-negative sepsis, with IL-18 levels
being highest in Gram-positive sepsis (47) and sCD14 highest
in Gram-negative sepsis (34). Combining these two proteins
could render us a tool for early differentiation between Gram-
positive and Gram-negative sepsis. Compared with classical
blood biomarkers of systemic inflammation (e.g., CRP), the
proteins detected in this study, including haptoglobin, vWF,
MBL1, MRC1, sCD14, and LBP, showed a very early response
to infection, indicating their potential in serving as new early
markers of infection or sepsis.
The preterm pig is the only model of sepsis in preterm
neonates that incorporates all the normal clinical signs of
prematurity, such as impaired immunity, respiratory distress,
and metabolic dysfunctions. It is highly relevant to study piglet
response to bacterial infection during the immediate postnatal
adaptation phase, which represents a highly sensitive period for
infections and maladaptation in preterm infants. However, it
cannot be excluded that the brain-related response to SE and
enteral feeding with bovind colsotrum would have been more
pronounced after longer exposure (beyond the first 24 h) to
SE and enteral feeding. Due to the extremely high technical
demand of this pig model, a non-inoculated but colostrum-fed
group was skipped. It remains to be investigated whether the
effect of colostrum feeding observed in this study is specific
to the highly bioactive bovine colostrum or if it is a general
effect of enteral feeding, independent of the diet type. Cerebral
and systemic responses may also vary according to gestational
age at birth, postnatal age, type of pathogen, and infection
intensity. Clearly, both pre-clinical and clinical studies are
required to clarify the several variables that affect the pathological
response to systemic bacterial infection and sepsis in preterm
neonates. Combined with proteomic analyses of plasma and
CSF, our animal model has shown a new path to investigate
both mechanisms and clinically relevant markers of sepsis in
preterm neonates.
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CONCLUSION
Our findings in this study may reflect how systemic infection
by Gram-positive bacteria soon after birth may affect brain
development and neuroinflammation in preterm infants. S.
epidermidis infection induced rapid changes in inflammation-
related CSF and the plasma proteome, and early enteral feeding
dampened the SE-induced changes in the plasma proteome, but
with limited effect in the CSF. The affected plasma proteins
may serve as new early biomarkers of Gram-positive systemic
infection in newborns, which may also affect central aspects of
neuroinflammation, such as microglia activation and blood–CSF
barrier disruption.
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